Press Releases April 17, 2026 04:10 PM

Sonoco To Report First Quarter 2026 Results

Sonoco to announce Q1 2026 results and host earnings webcast

By Derek Hwang
Share
Twitter Reddit Facebook LinkedIn
SON

Sonoco Products Company (NYSE: SON), a global leader in sustainable packaging, will report its first quarter 2026 financial results on April 21, 2026, followed by a conference call on April 22. The company highlights strong sustainability credentials and recognition in 2026 as one of the world's and America's most admired companies.

Sonoco To Report First Quarter 2026 Results
SON
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Sonoco will announce Q1 2026 results after market close on April 21, 2026, followed by a webcast and conference call on April 22.
  • The company operates globally with $7.5 billion in net sales (2025), 22,000 employees, and 265 operations in 37 countries.
  • Sonoco emphasizes its leadership in sustainable packaging and recognitions as one of the world's and America's most admired and responsible companies in 2026.

HARTSVLLE, S.C., April 17, 2026 (GLOBE NEWSWIRE) -- Sonoco Products Company (“Sonoco” or the “Company”)(NYSE: SON), a global leader in high-value sustainable packaging, will announce first quarter 2026 results on Tuesday, April 21, 2026 after the market closes. The Company will host a conference call to discuss these results on Wednesday, April 22, 2026, at 8:00 a.m. Eastern Time.

A live audio webcast of the call along with supporting materials will be available on the Sonoco Investor Relations website at https://investor.sonoco.com/. A webcast replay will be available on the Company's website for at least 30 days following the call. 

Event:                                     Sonoco First Quarter 2026 Earnings Webcast

  Time:Wednesday, April 22, 2026, at 8:00 a.m. Eastern Time  Audience Dial-In: To listen via telephone, please register in advance at https://registrations.events/direct/Q4I122827

Analysts and Participants will receive their unique dial in details with a PIN by email to join the conference call upon registration.

  Webcast Link: https://events.q4inc.com/attendee/192737512  

About Sonoco
Founded in 1899, Sonoco (NYSE: SON) is a global leader in value-added, sustainable metal and paper consumer and industrial packaging. The Company had net sales of $7.5 billion from continuing operations in 2025 and has approximately 22,000 employees working in 265 operations in 37 countries, serving some of the world’s best-known brands. Guided by our purpose of Better Packaging. Better Life., we strive to foster a culture of innovation, collaboration and excellence to provide solutions that better serve all our stakeholders and support a more sustainable future. Sonoco was proudly named one of the World’s Most Admired Companies by Fortune in 2026 as well as one of America’s Most Admired and Responsible Companies by Fortune and Newsweek and by USA TODAY’s list of America’s Climate Leaders. For more information on the Company, visit our website at www.sonoco.com.

Contact: Roger Schrum 
843-339-6018                                                                                                                                                                                 [email protected]


Risks

  • The press release is an earnings announcement notice without substantive financial or operational details, creating uncertainty on actual performance versus market expectations.
  • Global economic conditions or material supply chain disruptions could impact Sonoco's operations and reported results.
  • The sustainability and ESG reputation, while positive, may pose risks if future performance or policies do not align with investor or market expectations.

More from Press Releases

Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease Jun 13, 2026 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026 Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema Jun 13, 2026 Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 12, 2026 Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1 Jun 12, 2026